IDEAS home Printed from https://ideas.repec.org/a/oup/scippl/v50y2023i1p42-58..html
   My bibliography  Save this article

The industry of therapeutic monoclonal antibodies in Brazil: Public policies as instruments of technology upgrading

Author

Listed:
  • Renan G L
  • Bruno B
  • Paola R
  • Hillegonda M D

Abstract

Therapeutic monoclonal antibodies (MAbs) are biopharmaceuticals prescribed in oncology, rheumatology, and for other chronic and autoimmune diseases. Over the last decade, the demand for MAbs grew significantly in developing countries like Brazil, concomitant to the restructuring of the global biopharmaceutical industry, opening windows of opportunities for catching-up economies. This paper aims to analyze the capacity of a public policy, the so-called Production Development Partnership Program (PDPP), to encourage the generation of national capabilities to the local biopharmaceutical industry and technological upgrading in the biopharmaceutical sector in Brazil. It is a case study supported by qualitative data from twenty-three interviews. By focusing on technology transfer processes rather than on more complex strategies of technological learning and upgrading in domestic agents, the impact of PDPP has been marginal. We draw insights from this empirical appraisal to outline some lessons and challenges involved in the implementation of technology-upgrading policies in developing countries.

Suggested Citation

  • Renan G L & Bruno B & Paola R & Hillegonda M D, 2023. "The industry of therapeutic monoclonal antibodies in Brazil: Public policies as instruments of technology upgrading," Science and Public Policy, Oxford University Press, vol. 50(1), pages 42-58.
    • Handle: RePEc:oup:scippl:v:50:y:2023:i:1:p:42-58.
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1093/scipol/scac047
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:oup:scippl:v:50:y:2023:i:1:p:42-58.. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Oxford University Press (email available below). General contact details of provider: https://academic.oup.com/spp .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.